Evidence map›Paper›PMID 40679863›Full record

ArticleJournal of the American Society of Nephrology : JASN2026

Effects of Dapagliflozin on Health-Related Quality of Life in Patients with CKD.

Wisanne M Bakker, Hiddo J L Heerspink, Niels Jongs, Ricardo Correa-Rotter, Peter Rossing, Robert D Toto, David C Wheeler, John J V McMurray, Anna Maria Langkilde, Ron T Gansevoort and 2 more

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Longitudinal impact of sodium bicarbonate therapy on health-related quality of life in pre-dialysis chronic kidney disease with metabolic acidosis: a pragmatic trial in Malaysia.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Trial
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Wisanne M BakkerDepartment of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0009-0008-7203-3959
Hiddo J L HeerspinkDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-3126-3730
Niels JongsDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-0882-3656
Ricardo Correa-RotterThe National Medical Science and Nutrition Institute Salvador Zubiran, Mexico City, Mexico.
Peter RossingSteno Diabetes Center Copenhagen, Gentofte, Denmark.ORCID 0000-0002-1531-4294
Robert D TotoDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas.ORCID 0000-0001-9531-1749
David C WheelerDepartment of Renal Medicine, University College London, London, United Kingdom.ORCID 0000-0003-0745-3478
John J V McMurrayInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.ORCID 0000-0002-6317-3975
Anna Maria LangkildeBioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.ORCID 0000-0002-1696-9356
Ron T GansevoortDepartment of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-3223-0906
Glenn M ChertowDepartments of Medicine and Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California.ORCID 0000-0002-7599-0534
Priya VartDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Funding

AstraZeneca
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic kidney diseasechronic kidney failurechronic renal failurechronic renal insufficiencyCKDhealth statusoutcomespatient self-assessmentquality of liferandomized controlled trials

Identifiers

PMID40679863
PMCPMC12807183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.